Japan’s Nippon Chemiphar Co Ltd says it has successfully managed to reduce the company’s rate of year-on-year decline in its pharmaceutical sales from 7.5% in the second quarter to the 3% decline cited as the firm reported results for the first nine months of its financial year ending 31 March 2021.
The company reported pharmaceuticals sales of ¥22.97bn ($220m) for the first nine months of the financial year, compared to ¥23.67bn...




